Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FABP5 | Q01469 | 3/20 | 0.46 |
| ▸ | FABP7 | O15540 | 2/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.41 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.39 |
| ▸ | S1PR1 | P21453 | 1/20 | 0.37 |
| ▸ | S1PR5 | Q9H228 | 1/20 | 0.37 |
| ▸ | CA1 | P00915 | 1/20 | 0.37 |
| ▸ | CA2 | P00918 | 1/20 | 0.37 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.37 |
| ▸ | MDM4 | O15151 | 1/20 | 0.36 |
| ▸ | TP53 | P04637 | 1/20 | 0.36 |
| ▸ | AGTR2 | P50052 | 1/20 | 0.36 |
| ▸ | CASP3 | P42574 | 2/20 | 0.36 |
| ▸ | DPP8 | Q6V1X1 | 1/20 | 0.36 |
| ▸ | DPP9 | Q86TI2 | 1/20 | 0.36 |
| ▸ | NPC1 | O15118 | 1/20 | 0.35 |
| ▸ | RAB9A | P51151 | 1/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16838567 | 1.00 | FABP5 (0.46) | FABP5FABP7KMT2AEPHX2S1PR1 | |
| SCHEMBL7606819 | 1.00 | FABP5 (0.46) | FABP5FABP7KMT2AEPHX2S1PR1 | |
| SCHEMBL16838566 | 1.00 | FABP5 (0.46) | FABP5FABP7KMT2AEPHX2S1PR1 | |
| SCHEMBL8127912 | 0.89 | FABP5 (0.46) | FABP5FABP7KMT2AEPHX2CA1 | |
| SCHEMBL8121431 | 0.88 | FABP5 (0.45) | FABP5FABP7KMT2AEPHX2OPRD1 | |
| SCHEMBL1334889 | 0.88 | FABP5 (0.46) | FABP5FABP7KMT2AEPHX2 | |
| SCHEMBL4612189 | 0.88 | FABP5 (0.46) | FABP5FABP7KMT2AEPHX2 | |
| SCHEMBL16153163 | 0.88 | FABP5 (0.46) | FABP5FABP7KMT2AEPHX2CA1 | |
| SCHEMBL1000852 | 0.88 | FABP5 (0.46) | FABP5FABP7KMT2AEPHX2 | |
| SCHEMBL1336708 | 0.88 | FABP5 (0.46) | FABP5FABP7KMT2AEPHX2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120122803-A1 | ALPHA-CONOTOXIN MII ANALOGS | UNIVERSITY OF UTAH RESEARCH FOUNDATION (US) | 2012-05-17 | — | — | US | disclosed |
| US-8101573-B2 | α-conotoxin MII analogs | UNIVERSITY OF UTAH RESEARCH FOUNDATION (US) | 2012-01-24 | — | — | US | disclosed |
| US-20110064668-A1 | J-SUPERFAMILY CONOTOXIN PEPTIDES | UNIVERSITY OF UTAH RESEARCH FOUNDATION (US) | 2011-03-17 | — | — | US | disclosed |
| US-20090005316-A1 | ALPHA-CONOTOXIN MII ANALOGS | UNIVERSITY OF UTAH (US) | 2009-01-01 | — | — | US | disclosed |
| US-7387997-B2 | α-conotoxin MII analogues | UNIVERSITY OF UTAH (US) | 2008-06-17 | — | — | US | disclosed |
| US-20080089844-A1 | Kappam-conopeptides as organ protectants | OLIVERA BALDOMERO M | 2008-04-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120122803-A1 | ALPHA-CONOTOXIN MII ANALOGS | CHRNA6, CHRNG, CHRNA1 | FABP5 2135/4885FABP7 1414/4885KMT2A 2782/4885 |
| US-20090005316-A1 | ALPHA-CONOTOXIN MII ANALOGS | CHRNA6, CHRNG, CHRNA1 | FABP5 2135/4885FABP7 1414/4885KMT2A 2782/4885 |
| US-20110064668-A1 | J-SUPERFAMILY CONOTOXIN PEPTIDES | KCNQ1, KCNQ2, KCNA3 | FABP5 1647/4885FABP7 791/4885KMT2A 2701/4885 |
| US-20080089844-A1 | Kappam-conopeptides as organ protectants | VIP, KLK1, KLKB1 | FABP5 2530/4885FABP7 490/4885KMT2A 2349/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.